Results 71 to 80 of about 13,606,645 (327)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, Volume 20, Issue 6, Page 1626-1642, June 2026.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

A Network Analysis of the Impact of the Coronavirus Pandemic on the US Economy: A Comparison of the Return and the Momentum Picture

open access: yesEntropy
This study examines a cross-correlation analysis of companies included in the S&P 500 Index at three different intervals: before, during, and after the pandemic’s onset.
Janusz Miśkiewicz
doaj   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, Volume 20, Issue 6, Page 1453-1472, June 2026.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Time and memory in time series analysis [PDF]

open access: yesEpidemiologia e Serviços de Saúde, 2023
Flávia Reis de Andrade   +1 more
doaj   +1 more source

Forecasting Techniques for Univariate Time Series Data: Analysis and Practical Applications by Category

open access: yesComputer Sciences & Mathematics Forum
Effective forecasting is vital in various domains as it supports informed decision-making and risk mitigation. This paper aims to improve the selection of appropriate forecasting methods for univariate time series.
Leonard Dervishi   +2 more
doaj   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Contextual Analysis of Financial Time Series

open access: yesMathematics
The evaluation of the financial state of small and medium-sized companies is a pressing issue today. This article introduces a novel method to evaluate a company’s financial state, implemented as a module within a decision support system.
Nadezhda Yarushkina   +2 more
doaj   +1 more source

Moving forward with time series analysis

open access: yesResearch & Politics, 2017
In a recent Research and Politics article, we showed that for many types of time series data, concerns about spurious relationships can be overcome by following standard procedures associated with cointegration tests and the general error correction ...
Peter K. Enns   +3 more
doaj   +1 more source

Empirical Analysis of Time Series [PDF]

open access: yes
Time series occur in many fields of biology, physics, chemistry, engineering. Much work has been recently performed in statistical physics using specific mathematical techniques on various time series pertaining to so-called nonlinear phenomena.
Ausloos, M
core  

Topological Time Series Analysis

open access: yesNotices of the American Mathematical Society, 2019
Time series are ubiquitous in our data rich world, Jose A Perea describes how ideas from dynamical systems and topological data analysis can be combined to gain insights from time-varying data.
openaire   +2 more sources

Home - About - Disclaimer - Privacy